logo
Emerging future issues in HIV/AIDS social research
Complete removal of HIV-1 RNA and proviral DNA from semen by the swim-up method: assisted reproduction technique using spermatozoa free from HIV-1
A killer mimotope with therapeutic activity against AIDS-related opportunistic micro-organisms inhibits ex-vivo HIV-1 replication
Reverse transcriptase mutations 118I, 208Y, and 215Y cause HIV-1 hypersusceptibility to non-nucleoside reverse transcriptase inhibitors
Fluorodeoxyglucose imaging in healthy subjects with HIV infection: impact of disease stage and therapy on pattern of nodal activation
Decay of K103N mutants in cellular DNA and plasma RNA after single-dose nevirapine to reduce mother-to-child HIV transmission
Effect of pravastatin on body composition and markers of cardiovascular disease in HIV-infected men—a randomized, placebo-controlled study
Reconstitution of antimycobacterial immune responses in HIV-infected children receiving HAART
Antiretroviral medications associated with elevated blood pressure among patients receiving highly active antiretroviral therapy
Direct measurement of in-vivo vaginal microbicide levels of PRO 2000 achieved in a human safety study
Marked HIV prevalence declines in higher educated young people: evidence from population-based surveys (1995–2003) in Zambia
Clinical safety of HIV lipopeptides used as vaccines in healthy volunteers and HIV-infected adults
Herpes simplex virus infection in women in the WIHS: Epidemiology and effect of antiretroviral therapy on clinical manifestations
This is no time to stop use of nevarapine to prevent mother-to-child transmission of HIV
Statins in HIV-associated lipodystrophy and metabolic syndrome: is there a missing link?
Of molecules, macaques and global AIDS
Progression to AIDS and death in the era of HAART
The genotypic inhibitory quotient and the (cumulative) number of mutations predict the response to lopinavir therapy
Prevalence of the HIV-1 protease mutation I47A in clinical practice and association with lopinavir resistance
Potential for HIV transmission through unsafe injections
No association between GB virus C infection and disease progression in HIV-2-infected patients from the French ANRS HIV-2 cohort
Cotrimoxazole prophylaxis in adults with HIV and mortality among their HIV-negative children
Does cotrimoxazole taken by HIV-infected individuals reduce mortality among HIV-uninfected family members? Data may not support conclusion
Exposure to HIV and antiretroviral medication as a potential cause of necrotizing enterocolitis in term neonates
Maintenance of successful ritonavir-boosted indinavir and efavirenz therapy in an HIV-infected patient with tuberculosis
Plasma and cerebrospinal pharmacokinetics and pharmacodynamics in subjects taking lopinavir/ritonavir
Critical drug interaction between ritonavir-boosted atazanavir regimen and non-nucleoside reverse transcriptase inhibitors
Mesenteric panniculitis by cryptococcal infection in an HIV-infected man without severe immunosuppression
HIV prevention and treatment research in sub-Saharan Africa: where are the adolescents?
ERRATUM